<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HA2B512CA118440E5BDE6905486FBE182" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 8966 IH: COVID–19 Vaccine Awareness Support Act of 2020</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2020-12-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">116th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8966</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20201214">December 14, 2020</action-date><action-desc><sponsor name-id="W000815">Mr. Wenstrup</sponsor> (for himself, <cosponsor name-id="K000188">Mr. Kind</cosponsor>, <cosponsor name-id="M001198">Mr. Marshall</cosponsor>, <cosponsor name-id="P000608">Mr. Peters</cosponsor>, <cosponsor name-id="J000302">Mr. Joyce of Pennsylvania</cosponsor>, <cosponsor name-id="K000394">Mr. Kim</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn</cosponsor>, and <cosponsor name-id="S001165">Mr. Sires</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To provide for a vaccine safety public awareness campaign.</official-title></form><legis-body id="H3CAC131CBD3D4DE288DAC278CBF20EA8" style="OLC"><section id="HBF9147AF785442769B1A5D32D161F833" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>COVID–19 Vaccine Awareness Support Act of 2020</short-title></quote>.</text></section><section id="H8C8253A61CAD4A1F9C461B4D1F498F21"><enum>2.</enum><header>Vaccine safety public awareness campaign</header><subsection id="H83EFF00608F94429B872BD14E6A336E8"><enum>(a)</enum><header>In general</header><text>The Secretary of Health and Human Services (referred to in this section as the <quote>Secretary</quote>), acting through the Director of the Centers for Disease Control and Prevention and in coordination with the Office of Minority Health and the Federal Office of Rural Health Policy of the Department of Health and Human Services, and, as appropriate, with the relevant Offices of Minority Health of the Department of Health and Human Services, the National Institute on Minority Health and Health Disparities, and the Indian Health Service, shall establish grant funding opportunities for eligible entities to carry out a national, evidence-based campaign to disseminate COVID–19 vaccination information.</text></subsection><subsection id="H6815C1267B404DBA831EBC1F6E6122EF"><enum>(b)</enum><header>Eligible entities</header><text>To be eligible to receive a grant under this section, an entity shall—</text><paragraph id="HB6F1C68EB8D549F59A568C71691B36BD"><enum>(1)</enum><text>be a State, local, Tribal, or territorial health department, an urban Indian organization (as defined in section 4 of the Indian Health Care Improvement Act (<external-xref legal-doc="usc" parsable-cite="usc/25/1603">25 U.S.C. 1603</external-xref>)), a nonprofit community-based organization, or a nonprofit faith-based organization; and</text></paragraph><paragraph id="H4186028670844112A9C58C39643AC478"><enum>(2)</enum><text>agree to—</text><subparagraph id="H9B97292CB52840D3AA32235CBBC5110F"><enum>(A)</enum><text>work in consultation with relevant State and local health officials, health care providers, health care facilities, and other appropriate stakeholders to carry the campaign under this section; and</text></subparagraph><subparagraph id="HD94E18A85197479AB60C9146EC65D14C"><enum>(B)</enum><text>submit to the Secretary, within 30 days of receipt of a grant, a proposed plan for use of the grant funds.</text></subparagraph></paragraph></subsection><subsection id="HF1B36D19F87B4237AD29A0FB56F1546A"><enum>(c)</enum><header>Use of funds</header><paragraph id="H421853545B8543C5B8FB2FC5845929E9"><enum>(1)</enum><header>In general</header><text>Entities receiving a grant under this section shall use such grant funds to—</text><subparagraph id="H5ABFA6D57A81498B919046342370B598"><enum>(A)</enum><text>increase awareness and knowledge of the safety and effectiveness of vaccines approved or authorized by the Food and Drug Administration for the prevention and control of COVID–19 and the benefit of receiving a COVID–19 vaccine;</text></subparagraph><subparagraph id="HC6E56B0AE3B343B19722788FE53DB11F"><enum>(B)</enum><text>provide information on where the vaccine can be obtained; and</text></subparagraph><subparagraph id="H641E484790214071B9D345B000526AA5"><enum>(C)</enum><text>create multilingual and culturally appropriate messaging to disseminate scientific and evidence-based information related to vaccines.</text></subparagraph></paragraph><paragraph id="HB66553B073FE48C4991C6643A0200885"><enum>(2)</enum><header>Details of campaigns</header><text>Information disseminated by an entity receiving a grant under this section shall—</text><subparagraph id="HC9C6F73BB85944C9A08A15399EFCF4AA"><enum>(A)</enum><text>be based on available scientific evidence;</text></subparagraph><subparagraph id="H47CE1F40A00F497882AB2227A3D462F0"><enum>(B)</enum><text>increase awareness and knowledge of COVID–19, including countering stigma associated with COVID–19;</text></subparagraph><subparagraph id="H347AFB0ED5274290937975AF7ECDDAE6"><enum>(C)</enum><text>improve information on the availability of COVID–19 vaccines, including countering misinformation and disinformation with evidence-based scientific rebuttals; and</text></subparagraph><subparagraph id="H529198DED0544CCFAEE83324CA09EC60"><enum>(D)</enum><text>improve awareness and knowledge of coverage of COVID–19 vaccines.</text></subparagraph></paragraph></subsection><subsection id="H35B44692B13A474A80FF7E600DB321DA"><enum>(d)</enum><header>Prioritization</header><text>In awarding grants under this section, the Secretary shall give priority to eligible entities in either urban or rural communities (or a combination of urban and rural communities) that serve vulnerable populations, including communities of color, which may include low-income, uninsured, and medically underserved individuals or populations with historically low rates of receiving vaccines.</text></subsection><subsection id="H75D1E8C715084EE98D82D600E7B8F05A"><enum>(e)</enum><header>Timing</header><text>The Secretary shall awards the grants under this section not later than 30 days after the earlier of—</text><paragraph id="H6AEAC904A288475A8B0BA2174BC77773"><enum>(1)</enum><text>the date on which the Food and Drug Administration licenses a COVID–19 vaccine under section 351 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/262">42 U.S.C. 262</external-xref>); or</text></paragraph><paragraph id="H5E9CEAA180444D3E802DA16F48BA61DB"><enum>(2)</enum><text>the date on which a manufacturer begins to distribute a COVID–19 vaccine to public or private entities pursuant to an emergency use authorization under section 564 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360bbb-3">21 U.S.C. 360bbb–3</external-xref>).</text></paragraph></subsection><subsection id="HF43A3E0D96EA4ABBAD33FCB8D19B4B91"><enum>(f)</enum><header>Evaluation</header><text>The Secretary shall—</text><paragraph id="H03380EE1DE2D4874834388490C1101B7"><enum>(1)</enum><text>conduct qualitative assessments regarding the campaign under this section; and</text></paragraph><paragraph id="H6E8F156B480E43B8A1127ED3D06647A0"><enum>(2)</enum><text>not later than one year after the date of enactment of this Act, prepare and submit to the Committee on Appropriations and the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Appropriations and the Committee on Energy and Commerce of the House of Representatives an evaluation of the campaign under this section.</text></paragraph></subsection><subsection id="H6B63C78A3C724047A52072C599B6B236"><enum>(g)</enum><header>Authorization of appropriations</header><text>There is authorized to be appropriated to carry out this section such sums as may be necessary for fiscal year 2021.</text></subsection></section></legis-body></bill> 

